UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoxia‐Dependent Retinal Toxicity of NLCQ‐1 (NSC 709257) in BALB/c Mice. Comparison with Tirapazamine

Basic & clinical pharmacology & toxicology, 2011-06, Vol.108 (6), p.396-399

2011

Volltextzugriff (PDF)

NLCQ-1 (NSC 709257) in Combination with Radiation Against Human Glioma U251 Xenografts

Anticancer research, 2005-05, Vol.25 (3B), p.1865-1869

2005

Volltextzugriff (PDF)

Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice

Cancer chemotherapy and pharmacology, 2001-08, Vol.48 (2), p.160-168

2001

Volltextzugriff (PDF)

NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivo

International journal of radiation oncology, biology, physics, 1998-11, Vol.42 (4), p.775-779

1998

Volltextzugriff (PDF)

Novel Non-invasive Probes for Measuring Tumor-hypoxia by 19F-Magnetic Resonance Spectroscopy (19F-MRS). Studies in the SCCVII/C3H Murine Model

Anticancer research, 2006-09, Vol.26 (5A), p.3259-3263

2006

Volltextzugriff (PDF)

Novel Fluorinated Hypoxia-targeted Compounds as Non-invasive Probes for Measuring Tumor-hypoxia by 19F-Magnetic Resonance Spectroscopy (19F-MRS)

Anticancer research, 2006-09, Vol.26 (5A), p.3253-3258

2006

Volltextzugriff (PDF)

4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine

Oncology research, 2001-08, Vol.12 (8), p.325-333

2001

Volltextzugriff (PDF)

Synergistic enhancement of the antitumor effect of taxol by the bioreductive compound NLCQ-1, in vivo: comparison with tirapazamine

Oncology research, 2002, Vol.13 (1), p.47-54

2002

Volltextzugriff (PDF)

Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice

Cancer chemotherapy and pharmacology, 2002-12, Vol.50 (6), p.501-508

2002

Volltextzugriff (PDF)

Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia

International journal of cancer, 2001-11, Vol.94 (4), p.564-571

2001

Volltextzugriff (PDF)

9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer

Oncology research, 1996, Vol.8 (10-11), p.425

1996

Volltextzugriff (PDF)

9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I

Oncology research, 1997, Vol.9 (5), p.249

1997

Volltextzugriff (PDF)

Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration

Brain (London, England : 1878), 2013-07, Vol.136 (Pt 7), p.2130-2146

2013

Volltextzugriff (PDF)

Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system

Human molecular genetics, 2012-02, Vol.21 (4), p.874-889

2012

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Animals
(14)
Medical Sciences
(13)
Female
(12)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Mice, Inbred Balb C
(9)
Pharmacology. Drug Treatments
(9)
Antineoplastic Agents
(7)
Humans
(7)
Oncology
(7)
Nlcq-1
(6)
Antineoplastic Agents - Pharmacology
(5)
Chemotherapy
(5)
Drug Synergism
(5)
Mice, Inbred C3h
(5)
Quinolines - Pharmacology
(5)
Tirapazamine
(5)
Tumor Cells, Cultured
(5)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoxia‐Dependent Retinal Toxicity of NLCQ‐1 (NSC 709257) in BALB/c Mice. Comparison with Tirapazamine

NLCQ-1 (NSC 709257) in Combination with Radiation Against Human Glioma U251 Xenografts

Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice

NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivo

Novel Non-invasive Probes for Measuring Tumor-hypoxia by 19F-Magnetic Resonance Spectroscopy (19F-MRS). Studies in the SCCVII/C3H Murine Model

Novel Fluorinated Hypoxia-targeted Compounds as Non-invasive Probes for Measuring Tumor-hypoxia by 19F-Magnetic Resonance Spectroscopy (19F-MRS)

4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine

Synergistic enhancement of the antitumor effect of taxol by the bioreductive compound NLCQ-1, in vivo: comparison with tirapazamine

Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice

Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia

9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer

9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I

Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration

Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system

Aktive Filter

Suchergebnisse filtern